M. Altenbuchinger

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

R. Spang, A. Rosenwald, M. Ziepert, 2019, Leukemia.

Automated macrophage counting in DLBCL tissue samples: a ROF filter based approach

Julia Richter, Rainer Spang, Marcus Wagner, 2019, Biological Procedures Online.

Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining

R. Spang, A. Rosenwald, W. Klapper, 2018, Virchows Archiv.

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients

L. Trümper, S. Dietrich, R. Schroers, 2023, HemaSphere.

Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma

P. Borchmann, A. Plütschow, P. Bröckelmann, 2024, HemaSphere.

Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma

R. Spang, A. Rosenwald, M. Ziepert, 2020, Leukemia & lymphoma.